Back to Search Start Over

P-selectin targeting polysaccharide-based nanogels for miRNA delivery

Authors :
Joana C. Antunes
Fernanda C. Moraes
Murielle Maire
Didier Letourneur
Samira Benadda
Cédric Chauvierre
Rachida Aid
Laura Marcelo Forero Ramirez
Frédéric Chaubet
Source :
International Journal of Pharmaceutics. 597:120302
Publication Year :
2021
Publisher :
Elsevier BV, 2021.

Abstract

Nanogels were prepared in aqueous media without the use of any organic solvent via a simple polyelectrolyte complexation method between aminated pullulan and fucoidan followed by covalent crosslinking with genipin. Homogeneously distributed genipin crosslinked nanogels (G-PECs) were obtained with a mean hydrodynamic diameter of ~155 nm and zeta potential of 0.86 ± 4.35 mV. Their capacity to bind to human activated platelets was evaluated in vitro, as well as their cytocompatibility within human endothelial cells after 1 day of incubation up to 1000 µg/mL of G-PECs (94.56 ± 7.82% of viable cells). Additional hemolysis tests support the biocompatible character of the developed nanosystems (hemolysis rate of 2.09 ± 0.06% for 1000 µg/mL of G-PECs). Under acid conditions, the surface charge of G-PECs was tuned to around ~10 mV allowing miRNA incorporation via electrostatic interactions. G-PECs were able to promote miRNA delivery inside cells, as demonstrated by fluorescence microscopy images of labelled miRNA. With further studies to demonstrate the biological activity of delivered miRNA, these nanogels could be an interesting platform for miRNA-based therapeutics in atherothrombotic-related diseases thanks to the possibility to target over-expressed P-selectin.

Details

ISSN :
03785173
Volume :
597
Database :
OpenAIRE
Journal :
International Journal of Pharmaceutics
Accession number :
edsair.doi.dedup.....573b1066facd823fb7af81c10c8647e1
Full Text :
https://doi.org/10.1016/j.ijpharm.2021.120302